Cargando…
Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients
Multiple studies have reported a doubling in risk of Coronavirus Disease-2019 (COVID-19) among cancer patients. Here, we examine the potential biological rationale behind this recurrent epidemiological observation. By leveraging large-scale genome-wide transcriptional data of normal and malignant ti...
Autores principales: | Kwan, Jennifer Yin Yee, Lin, Liang-Tzung, Bell, Rachel, Bruce, Jeffrey P., Richardson, Christopher, Pugh, Trevor J., Liu, Fei-Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907391/ https://www.ncbi.nlm.nih.gov/pubmed/33633121 http://dx.doi.org/10.1038/s41598-021-83366-y |
Ejemplares similares
-
Innate immunity modulation in virus entry
por: Faure, Mathias, et al.
Publicado: (2011) -
Loss of CARD9-mediated innate activation attenuates severe influenza pneumonia without compromising host viral immunity
por: Uematsu, Takayuki, et al.
Publicado: (2015) -
Innate immunology in COVID-19—a living review. Part I: viral entry, sensing and evasion
por: Coveney, Clarissa, et al.
Publicado: (2020) -
Ubiquitin in Influenza Virus Entry and Innate Immunity
por: Rudnicka, Alina, et al.
Publicado: (2016) -
Amphotericin B Inhibits Enterovirus 71 Replication by Impeding Viral Entry
por: Xu, Fengwen, et al.
Publicado: (2016)